v3.26.3
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities    
Net income $ 20,942 $ 14,002
Adjustments to Reconcile Net Income to Cash Flows from Operating Activities:    
Depreciation and amortization 1,588 1,411
Change in deferred income taxes (1,098) (959)
Stock-based compensation expense 562 490
Acquired in-process research and development 7,541 2,381
Other changes in operating assets and liabilities, net of acquisitions and divestitures (1,899) (4,419)
Other operating activities, net (216) 682
Net Cash Provided by Operating Activities 27,420 13,588
Cash Flows from Investing Activities    
Purchases of property and equipment (8,437) (5,294)
Purchases of noncurrent investments (862) (518)
Purchases of in-process research and development (7,548) (2,584)
Cash paid for acquisitions, net of cash acquired (10,692) (549)
Other investing activities, net (72) 776
Net Cash Used for Investing Activities (27,611) (8,169)
Cash Flows from Financing Activities    
Dividends paid (4,635) (4,039)
Net change in short-term borrowings 0 (4,338)
Proceeds from issuance of long-term debt 8,941 13,167
Repayments of long-term debt (1,623) (778)
Purchases of common stock (4,334) (2,600)
Other financing activities, net (612) (746)
Net Cash (Used for) Provided by Financing Activities (2,263) 666
Effect of exchange rate changes on cash and cash equivalents 71 439
Net (decrease) increase in cash and cash equivalents (2,383) 6,524
Cash and cash equivalents at January 1 7,268 3,268
Cash and Cash Equivalents at September 30 $ 4,885 $ 9,792